Periodontal status of the Rheumatoid Arthritis patients under rituximab treatment: A case control Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20191215003

Enrollment

Registered

2019-12-15

Start date

2017-11-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal health Periodontitis&#44

Interventions

Patients Who are under rituximab therapy for rheumatoid arthritis,Patients Who are under DMARD therapy for rheumatoid arthritis,Systemically healthy individuals

Screening,Screening,Screening

Rituximab,DMARD,Control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: To be under rituximab or DMARD treatment for RA

Exclusion criteria

Exclusion criteria: To have diabetes, CVD, pregnant and smoking

Design outcomes

Primary

Measure	Time frame
IL-1b, MMP-8 30 sec NG/30sec	—

Secondary

Measure	Time frame
Behavior outcome Baseline, Post immediately, follow up at 1 week assessment tool	—

Countries

TÃ¼rkiye

Contacts

Public Contactkemal Ã¼stÃ¼n

Assoc.Prof.Dr.

kemalustun@hotmail.com+905057246961

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026